NYSEAMERICAN:XTNT Xtant Medical (XTNT) Stock Price, News & Analysis $0.57 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.56▼$0.6050-Day Range N/A52-Week Range$0.51▼$1.45Volume43,432 shsAverage Volume112,966 shsMarket Capitalization$73.64 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest Get Xtant Medical alerts: Email Address Xtant Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside430.9% Upside$3.00 Price TargetShort InterestHealthy0.50% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.02 out of 5 stars 3.5 Analyst's Opinion Consensus RatingXtant Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageXtant Medical has received no research coverage in the past 90 days.Read more about Xtant Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.50% of the float of Xtant Medical has been sold short.Short Interest Ratio / Days to CoverXtant Medical has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xtant Medical has recently increased by 22.41%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldXtant Medical does not currently pay a dividend.Dividend GrowthXtant Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XTNT. Previous Next 2.7 News and Social Media Coverage News SentimentXtant Medical has a news sentiment score of 1.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Xtant Medical this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Xtant Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Xtant Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.70% of the stock of Xtant Medical is held by insiders.Percentage Held by Institutions69.33% of the stock of Xtant Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Xtant Medical's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Xtant Medical is -56.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Xtant Medical is -56.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXtant Medical has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm Press Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.Full details are in this announcement. About Xtant Medical Stock (NYSEAMERICAN:XTNT)Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.Read More XTNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XTNT Stock News HeadlinesAugust 10, 2024 | seekingalpha.comXtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | finanznachrichten.deXtant Medical Holdings, Inc.: Xtant Medical Announces Closing of $5.0 Million Private PlacementSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.August 9, 2024 | finanznachrichten.deXtant Medical Holdings, Inc.: Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%August 8, 2024 | investorplace.comXTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q2 2024July 30, 2024 | money.usnews.comXtant Medical Holdings IncJuly 25, 2024 | finanznachrichten.deXtant Medical Holdings: Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company ShowcaseMay 22, 2024 | finanznachrichten.deXtant Medical Holdings, Inc.: Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29September 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.May 22, 2024 | finance.yahoo.comXtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29May 16, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Xtant Medical Holdings (XTNT), Teleflex (TFX) and Esperion (ESPR)May 16, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT) and Verrica Pharmaceuticals (VRCA)May 16, 2024 | msn.comXtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2024 Earnings Call TranscriptMay 16, 2024 | finance.yahoo.comXtant Medical Holdings Inc (XTNT) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...May 15, 2024 | markets.businessinsider.comWhat Wall Street expects from Xtant Medical's earningsMay 15, 2024 | finanznachrichten.deXtant Medical Holdings, Inc.: Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue GuidanceMay 15, 2024 | finance.yahoo.comXtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue GuidanceMay 1, 2024 | markets.businessinsider.comCraig-Hallum Reaffirms Their Buy Rating on Xtant Medical Holdings (XTNT)See More Headlines Receive XTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNYSEAMERICAN:XTNT Previous SymbolAMEX:XTNT CUSIPN/A CIK1453593 Webxtantmedical.com Phone(406) 388-0480Fax406-388-1354Employees120Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+430.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$660,000.00 Net Margins-3.00% Pretax Margin-4.46% Return on Equity-6.71% Return on Assets-3.56% Debt Debt-to-Equity Ratio0.49 Current Ratio2.44 Quick Ratio1.01 Sales & Book Value Annual Sales$91.30 million Price / Sales0.81 Cash Flow$0.02 per share Price / Cash Flow25.11 Book Value$0.35 per share Price / Book1.61Miscellaneous Outstanding Shares130,310,000Free Float117,633,000Market Cap$73.64 million OptionableNot Optionable Beta0.38 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Sean E. Browne (Age 58)President, CEO & Director Comp: $1.29MMr. Mark A. Schallenberger (Age 38)Chief Operations Officer Comp: $778.42kMr. Kevin D. Brandt (Age 58)Senior VP & Chief Commercial Officer Comp: $658.03kMr. Scott C. Neils (Age 40)Chief Financial Officer Comp: $517.86kMs. Catherine LundyVice President of Human ResourcesKey CompetitorsTScan TherapeuticsNASDAQ:TCRXAlimera SciencesNASDAQ:ALIMJasper TherapeuticsNASDAQ:JSPRAkebia TherapeuticsNASDAQ:AKBACartesian TherapeuticsNASDAQ:RNACView All CompetitorsInstitutional OwnershipNantahala Capital Management LLCSold 420,000 shares on 8/20/2024Ownership: 2.748%Renaissance Technologies LLCSold 59,500 shares on 8/9/2024Ownership: 0.540%View All Institutional Transactions XTNT Stock Analysis - Frequently Asked Questions How were Xtant Medical's earnings last quarter? Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) announced its quarterly earnings data on Thursday, August, 8th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01. The medical device company earned $29.94 million during the quarter. Xtant Medical had a negative net margin of 3.00% and a negative trailing twelve-month return on equity of 6.71%. When did Xtant Medical's stock split? Xtant Medical's stock reverse split before market open on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Xtant Medical's major shareholders? Top institutional investors of Xtant Medical include Nantahala Capital Management LLC (2.75%) and Renaissance Technologies LLC (0.54%). Insiders that own company stock include Stavros G Vizirgianakis, Sean E Browne and Scott C Neils. View institutional ownership trends. How do I buy shares of Xtant Medical? Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Xtant Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Xtant Medical investors own include Aurinia Pharmaceuticals (AUPH), LadRx (CYTR), Heat Biologics (HTBX), Neovasc (NVCN), Rexahn Pharmaceuticals (REXN) and Biopharmx (BPMX). This page (NYSEAMERICAN:XTNT) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtant Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xtant Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
